Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells (Q39645392)

13 September 2017

Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells (English)

1 reference

13 September 2017

0 references

0 references

Andrea Kristina Horst

16

object named as

Andrea Kristina Horst

0 references

Georg Schett

13

object named as

Georg Schett

1 reference

13 September 2017

Andrew N. J. McKenzie

15

object named as

Andrew N J McKenzie

1 reference

13 September 2017

Jochen Schulze

1

1 reference

13 September 2017

Thomas Bickert

2

1 reference

13 September 2017

F Timo Beil

3

1 reference

13 September 2017

Mario M Zaiss

4

1 reference

13 September 2017

Joachim Albers

5

1 reference

13 September 2017

Kristofer Wintges

6

1 reference

13 September 2017

Thomas Streichert

7

1 reference

13 September 2017

Kristin Klaetschke

8

1 reference

13 September 2017

Johannes Keller

9

1 reference

13 September 2017

Tim-Nicolas Hissnauer

10

1 reference

13 September 2017

Alexander S Spiro

11

1 reference

13 September 2017

Andre Gessner

12

1 reference

13 September 2017

Michael Amling

14

1 reference

13 September 2017

Andrea Kristina Horst

16

1 reference

13 September 2017

Thorsten Schinke

17

1 reference

13 September 2017

language of work or name

1 reference

1 April 2011

1 reference

Journal of Bone and Mineral Research

13 September 2017

1 reference

13 September 2017

26

1 reference

13 September 2017

4

1 reference

13 September 2017

704-717

1 reference

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

13 September 2017

1 reference

Bone resorption by osteoclasts

21 January 2018

1 reference

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL

21 January 2018

1 reference

IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells.

21 January 2018

1 reference

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

21 January 2018

1 reference

Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family

21 January 2018

1 reference

IL-1, IL-18, and IL-33 families of cytokines

21 January 2018

1 reference

Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice

21 January 2018

1 reference

TNF-induced structural joint damage is mediated by IL-1.

21 January 2018

1 reference

Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.

21 January 2018

1 reference

Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity.

21 January 2018

1 reference

Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells

21 January 2018

1 reference

Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions

21 January 2018

1 reference

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses

21 January 2018

1 reference

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

IL-33 exacerbates antigen-induced arthritis by activating mast cells

21 January 2018

1 reference

The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation

21 January 2018

1 reference

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

Increased bone formation in mice lacking apolipoprotein E.

21 January 2018

1 reference

The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice

21 January 2018

1 reference

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

21 January 2018

1 reference

Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury

21 January 2018

1 reference

GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.

21 January 2018

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

Osteolytic prostate cancer cells induce the expression of specific cytokines in bone-forming osteoblasts through a Stat3/5-dependent mechanism

21 January 2018

1 reference

IL-33 can promote survival, adhesion and cytokine production in human mast cells

21 January 2018

1 reference

Cloning and characterization of osteoclast precursors from the RAW264.7 cell line

21 January 2018

1 reference

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

21 January 2018

1 reference

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

21 January 2018

1 reference

The IL-33/ST2 pathway: therapeutic target and novel biomarker

21 January 2018

1 reference

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

Interleukin-33 - cytokine of dual function or novel alarmin?

21 January 2018

1 reference

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket

21 January 2018

1 reference

IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway

21 January 2018

1 reference

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

21 January 2018

1 reference

Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils

21 January 2018

1 reference

Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity

21 January 2018

1 reference

Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1

21 January 2018

1 reference

NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).

21 January 2018

1 reference

DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells

21 January 2018

1 reference

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.269

1 reference

13 September 2017

1 reference